iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2022 | Series A | $65M | 1 | — | — | Detail |
| Sep 9, 2021 | Series A | $50M | 1 |
Versant Ventures
|
— | Detail |
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 29, 2022
Flourish Fi
|
Seed | $2.30M | Financial Services | — |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series A |